Cost to the patient (health insurance, Medicare, etc.) initially may be approximately $7305.00 per year and drop rather quickly to $3652.50 per year or lower when the numbers of patients world wide reaches in the tens of millions.
Blarcamesine is a rather simple small drug compound to produce so the cost to produce if negligible (I estimate less than $1.00 for a 50 mg capsule (pill).
Market Data 
Markets 
AI
